HAZEL PASCUAL-GONZALES: Open Payments
NPI 1023508033 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,004 in 38 payments from 16 companies in 2025. Trend: 2023 $107 · 2024 $111 · 2025 $1,004
Food & beverage: $904Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $380 |
| Ardelyx, Inc. | 3 | $130 |
| Celltrion USA Inc. | 3 | $71 |
| Gilead Sciences, Inc. | 3 | $56 |
| Lilly USA, LLC | 2 | $43 |
| Ipsen Biopharmaceuticals, Inc | 2 | $37 |
| Aimmune Therapeutics, Inc. | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| ABBVIE INC. | 2 | $36 |
Products named: TREMFYA, IBSRELA, VEGZELMA, OMVOH, IQIRVO, VOQUEZNA, XIFAXAN, DUPIXENT.
Industry payments across TX — which companies pay providers there.
